Jump to main content
Jump to site search


Synthesis and pharmaceutical characterization of site specific mycophenolic acid-modified Xenopus glucagon-like peptide-1 analogs

Author affiliations

Abstract

To develop novel long-acting antidiabetic agents, mycophenolic acid (MPA) was used to modify Xenopus glucagon-like peptide-1 analog (GLP-1) (1) at three Lys residues through a γ-glutamyl linker. Similarly, 6-aminocaproic acid and 12-aminolauric acid with different lengths of fatty chain were used as MPA derivatives which were then conjugated with 1. By using proper protection and deprotection strategies, the synthetic process was completed directly on the resin to minimize the side reactions, and nine MPA-modified 1 derivatives (2a–2i) were obtained. Compounds 2b and 2c, which showed high GLP-1 receptor activation potencies and glucose lowering activities, were selected for further C-terminal modification to improve their stabilities and bioactivities, giving compounds 3a–3d. The receptor activation potencies and hypoglycemic activities of 3a–3d were comparable to that of liraglutide. Physicochemical and in vitro stability tests revealed that MPA conjugation led to enhanced albumin binding abilities as reflected by the improved stabilities of 3a–3d. In particular, at a dose of 25 nmol kg−1, the in vivo antidiabetic and insulinotropic activities of 3d were comparable to those of semaglutide. Finally, long-term administration of 3d achieved beneficial effects on glucose tolerance normalization and glycated hemoglobin (HbA1c) lowering, and no hepatotoxicity was observed. In conclusion, this research demonstrated that MPA derivatization was a practical way to develop long-acting antidiabetic peptides.

Graphical abstract: Synthesis and pharmaceutical characterization of site specific mycophenolic acid-modified Xenopus glucagon-like peptide-1 analogs

Back to tab navigation

Supplementary files

Publication details

The article was received on 15 Sep 2017, accepted on 05 Nov 2017 and first published on 07 Nov 2017


Article type: Research Article
DOI: 10.1039/C7MD00471K
Citation: Med. Chem. Commun., 2017, Advance Article
  •   Request permissions

    Synthesis and pharmaceutical characterization of site specific mycophenolic acid-modified Xenopus glucagon-like peptide-1 analogs

    J. Han, J. Fu, L. Sun, Y. Han, Q. Mao, F. Liao, X. Zheng and K. Zhu, Med. Chem. Commun., 2017, Advance Article , DOI: 10.1039/C7MD00471K

Search articles by author

Spotlight

Advertisements